Change in the number of votes relating to Biotie Therapies Corp.'s shares

BIOTIE THERAPIES CORP.                  Stock Exchange Release            21 August 2014 at 10.05 am

Change in the number of votes relating to Biotie Therapies Corp.'s shares

Biotie Therapies Corp. ("Biotie" or the "Company") has conveyed Biotie shares held as treasury shares, that were issued on 2 January 2014, pursuant to the Stock Option Plan 2011 and the Equity Incentive Plan 2011 (the "Plans") as follows:

Shares  conveyed	Cumulative shares  conveyed since 2  January 2014	Remaining shares to  be conveyed
247,500	3,306,660	15,000

Under the Stock Option Plan 2011, the owners of the stock options may subscribe for a maximum total of 7,401,000 new shares in the Company or existing shares held by the Company. A total of 247,500 shares have been subscribed for during the period 30 July 2014 and 20 August 2014 and 247,500 of the treasury shares will be used for these share subscriptions. The subscription price of EUR 0.01 per share has been fully paid by the employee and the EUR 2,475 funds received will be credited to the Company's reserve for non-restricted equity.

Based on the Equity Incentive Plan 2011 no shares have been conveyed during the period 30 July 2014 and 20 August 2014.

The conveyed shares previously held as treasury shares have not carried any voting rights. The conveyance does not affect the number of registered shares. After the conveyances the changes are as follows:

Increase in number  of outstanding shares	Total amount of voting rights	Number of the Company's share held by the Group	Total number of registered shares
247,500	450,681,015	5,351,383	456,032,398

Turku, 21 August 2014

Biotie Therapies Corp.
Timo Veromaa, President and CEO

For further information, please contact:
Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp.
tel. [phone], e-mail: [e-mail]
www.biotie.com

DISTRIBUTION:
NASDAQ OMX Helsinki Ltd
Main Media 

---

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Biotie Therapies Oyj via Globenewswire

HUG#1850193